Clinical trials for Small cell carcinoma of the bladder
9 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- ENROLLING BY INVITATIONPhase 1NCT07218003A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Rondo Therapeutics · PI: Thomas Manley, MD
- RECRUITINGPhase 2NCT06161532Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...National Cancer Institute (NCI) · PI: Andrea B Apolo, M.D.
- RECRUITINGPhase 2NCT06228066Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)National Cancer Institute (NCI) · PI: Andrea B Apolo, M.D.
- RECRUITINGPhase 1NCT06257264A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage TumorsBeiGene · PI: Study Director
- RECRUITINGPhase 2NCT05312671Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · PI: Jean Hoffman-Censits, MD
- RECRUITINGNCT05621837Quantifying Systemic Immunosuppression to Personalize Cancer TherapyFondazione IRCCS Istituto Nazionale dei Tumori, Milano · PI: Licia Rivoltini
- ACTIVE NOT RECRUITINGNCT05219734MRD Assay Evaluates Recurrence and Response Via a Tumor Informed AssessmentInvitae Corporation · PI: Ed Esplin, MD, PhD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04644068Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesAstraZeneca · PI: Timothy Yap
- ACTIVE NOT RECRUITINGPhase 2NCT00756639Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the UrotheliumM.D. Anderson Cancer Center · PI: Seungtaek Choi, MD